Atul Kavthekar - 12 Dec 2022 Form 4 Insider Report for P3 Health Partners Inc. (PIII)

Role
Chief Financial Officer
Signature
/s/ Jessica Puathasnanon, as attorney-in-fact
Issuer symbol
PIII
Transactions as of
12 Dec 2022
Net transactions value
$0
Form type
4
Filing time
14 Dec 2022, 15:16:41 UTC
Next filing
16 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIII Stock Option (Right to Buy) Award $0 +600,000 $0.000000 600,000 12 Dec 2022 Class A Common Stock 600,000 $3.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the shares on December 12, 2023 (the "Initial Vesting Date"), and the remaining 75% will vest in equal annual installments over the following three years on each anniversary of the Initial Vesting Date, subject to the Reporting Person's continued service through the applicable vesting date.